Results 141 to 150 of about 13,895,504 (364)

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source

Can allergy patch tests with food additives help to diagnose the cause in childhood chronic spontaneous urticaria? [PDF]

Postepy Dermatol Alergol, 2020
Ozceker D, Dilek F, Yucel E, Tamay Z, Ozkaya E, Guler N.   +5 more
europepmc   +1 more source

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

Results of patch testing with lavender oil in Japan [PDF]

, 2000
Mariko Sugiura, Ritsuko Hayakawa, Yoshimi Kato, Keiji Sugiura, Rika Hashimoto   +4 more
openalex   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

High rate of sensitization to Kathon CG, detected by patch tests in patients with suspected allergic contact dermatitis. [PDF]

An Bras Dermatol, 2020
Silva EA, Bosco MRM, Lozano RR, Latini ACP, Souza VNB.   +4 more
europepmc   +1 more source

Diagnosis of Photosensitization Reactions by the Scotch Tape® Provocative Patch Test

, 1968
Isaac Willis, Albert M. Kligman
openalex   +1 more source

Positive nickel patch tests do not intensify positive reactions to adjacent patch tests with dichromate [PDF]

, 2000
Jochen Brasch, Bo Kreilgård, Tilo Henseler, Werner Aberer, Thomas Fuchs, Rafael Pflüger, Ulla Hoeck, Olaf Gefeller   +7 more
openalex   +1 more source

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Influence of Ultraviolet Light on Patch Tests*

, 1965
A.H. Mohajerin, Stephan Epstein
openalex   +1 more source